All In Biotech

Drug Trial Radar · NCT03147092

Matão Controlling Hypertension (MatCH Study): Rationale and Design

Matão Controlling Hypertension (MatCH Study): Rationale and Design. Project to Reduce Incidence of Arterial Hypertension in City of Matão, Brazil.

Last checked: Nov 19, 2026Latest source record: Nov 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

15,000

Planned (sponsor's estimate)

Start

Feb 1, 2018

Primary completion

Jun 30, 2020

Study completion Jun 30, 2021

Sponsor

Lead sponsor
Centro Neurológico de Pesquisa e Reabiitação, BrazilAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 10, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Background Hypertension is the main risk factor for most cardiovascular diseases. Blood pressure (BP) control has been shown to reduce the incidence of stroke, myocardial infarction, renal diseases and heart failure. Although BP lowering is effective, few population programs can achieve BP control. A coordinated and organized system from the Brazilian Ministry of Healthy involving Family Health Strategy (FHS), a program for the prevention of chronic disease, and the Popular Pharmacy Program (PPP), which subsidizes medications for the population, could allow an earlier identification and better BP control. Matão Controlling Hypertension (MatCH) is a community-based population project that aims to apply an organized, integrated and coordinated program in the city of Matão, Brazil, involving FSH and PPP in order to actively search, treat and follow-up hypertensive subjects. Method This is a population community-based, prospective, interventional, follow-up study where all subjects aged ≥ 40 years assisted by the FHS program in Matão will have BP assessed monthly by trained Community Health Agents (CHA) during a domiciliary visit. Identified hypertensive subjects will be referred to FHS physicians for nonpharmacological and pharmacological treatment. Most of the hypertensive drugs used will be available thought the PPP. Prevalence of hypertension, awareness, demographics and risk factors will be correlated with BP control. The population study is expected to involve approximately 15,000 subjects. The study period will be four years. Discussion Considering that hypertension is asymptomatic in most cases, to reduce the population burden of BP-related deaths and diseases it is essential to detect and treat early all hypertensive patients. If BP control be achieved on a large scale, this program can be applied to other populations from developing countries.

Conditions

  • Hypertension
  • Blood Pressure

Interventions

  • Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,Drug

    Treatment of hypertensive subjects

  • AtenololDrug

    Treatment of hypertensive subjects

  • Losartan potassium 50mgDrug

    Treatment of hypertensive subjects

  • ClonidineDrug

    Treatment of hypertensive subjects

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of hypertensive subjects with BP controlled during follow-upTime frame: Through study completion, an average of 2 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.